Multiple sclerosis: Fas signaling in oligodendrocyte cell death

被引:327
|
作者
DSouza, SD
Bonetti, B
Balasingam, V
Cashman, NR
Barker, PA
Troutt, AB
Raine, CS
Antel, JP
机构
[1] MCGILL UNIV,MONTREAL NEUROL INST,NEUROIMMUNOL UNIT,MONTREAL,PQ H3A 2B4,CANADA
[2] MCGILL UNIV,MONTREAL NEUROL INST,CTR NEURONAL SURVIVAL,DEPT NEUROL & NEUROSURG,MONTREAL,PQ H3A 2B4,CANADA
[3] IMMUNEX CORP,SEATTLE,WA 98101
[4] ALBERT EINSTEIN COLL MED,DEPT PATHOL NEUROPATHOL,BRONX,NY 10461
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1996年 / 184卷 / 06期
关键词
D O I
10.1084/jem.184.6.2361
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fas is a cell surface receptor that transduces cell death signals when cross-linked by agonist antibodies or by fas ligand. In this study, we examined the potential of fas to contribute to oligodendrocyte (OL) injury and demyelination as they occur in the human demyelinating disease multiple sclerosis (MS). Immunohistochemical study of central nervous system (CNS) tissue from MS subjects demonstrated elevated fas expression on OLs in chronic active and chronic silent MS lesions compared with OLs in control tissue from subjects with or without other neurologic diseases. In such lesions, microglia and infiltrating lymphocytes displayed intense immunoreactivity to ias ligand. In dissociated glial cell cultures prepared from human adult CNS tissue, fas expression was restricted to OLs. Fas Ligation with the anti-Eas monoclonal antibody M3 or with the fas-ligand induced rapid OL cell membrane lysis, assessed by LDH release and trypan blue uptake and subsequent cell death. In contrast to the activity of fas in other cellular systems, dying OLs did not exhibit evidence of apoptosis, assessed morphologically and by terminal transferase-mediated d-uridine triphosphate-biotin nick-end-labeling staining for DNA fragmentation. Other stimuli such as C2-ceramide were capable of inducing rapid apoptosis in OLs. Antibodies directed at other surface molecules expressed on OLs or the M33 nonactivating anti-fas monoclonal antibody did not induce cytolysis of OLs. Our results suggest that fas-mediated signaling might contribute in a novel cytolytic manner to immune-mediated OL injury in MS.
引用
收藏
页码:2361 / 2370
页数:10
相关论文
共 50 条
  • [21] A mathematical model of cell death in multiple sclerosis
    Broome, Taylor M.
    Coleman, Randolph A.
    JOURNAL OF NEUROSCIENCE METHODS, 2011, 201 (02) : 420 - 425
  • [22] T-Cell responses to oligodendrocyte-specific protein in multiple sclerosis
    Vu, T
    Myers, LW
    Ellison, GW
    Mendoza, F
    Bronstein, JM
    JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 66 (03) : 506 - 509
  • [23] Serum autoantibodies to oligodendrocyte and neuronal cell surface antigens in multiple sclerosis patients
    Lily, O
    Palace, J
    Vincent, A
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (01): : 137 - 137
  • [24] Apoptotic death following Fas activation in human oligodendrocyte hybrid cultures
    Li, WP
    Maeda, Y
    Ming, X
    Cook, S
    Chapin, J
    Husar, W
    Dowling, P
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 69 (02) : 189 - 196
  • [25] Oligodendrocyte guidance molecules in multiple sclerosis lesions
    Theaudin, M.
    Olivier, C.
    Aigrot, M. S.
    Bourre, Y.
    Reynolds, R.
    Sazdovitch, V.
    Chedotal, A.
    Zalc, B.
    Lubetzki, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 121 - 122
  • [26] Oligodendrocyte loss and preservation in early multiple sclerosis
    Lucchinetti, CF
    Rodriguez, M
    Bruck, W
    Scheithauer, BW
    Parisi, J
    Lassmann, H
    ANNALS OF NEUROLOGY, 1996, 40 (03) : M125 - M125
  • [27] Myelin oligodendrocyte glycoprotein polymorphisms and multiple sclerosis
    Gomez-Lira, M
    Moretto, G
    Bonamini, D
    Benedetti, MD
    Pignatti, PF
    Rizzuto, N
    Salviati, A
    JOURNAL OF NEUROIMMUNOLOGY, 2002, 133 (1-2) : 241 - 243
  • [28] Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis
    Dhib-Jalbut, Suhayl
    NEUROLOGY, 2007, 68 : S13 - S21
  • [29] Targeting Oligodendrocyte Protection and Remyelination in Multiple Sclerosis
    Zhang, Jingya
    Kramer, Elisabeth G.
    Mahase, Sean
    Dutta, Dipankar J.
    Bonnamain, Virginie
    Argaw, Azeb T.
    John, Gareth R.
    MOUNT SINAI JOURNAL OF MEDICINE, 2011, 78 (02): : 244 - 257
  • [30] Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis
    Gacem, Nadjet
    Nait-Oumesmar, Brahim
    LIFE-BASEL, 2021, 11 (04):